Smoking and lung cancer survival - The role of comorbidity and treatment

被引:209
作者
Tammemagi, CM
Neslund-Dudas, C
Simoff, M
Kvale, P
机构
[1] Josephine Ford canc Ctr, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Pulm Crit Care Med, Detroit, MI USA
关键词
comorbidity; lung neoplasm; smoking; survival; symptoms; treatment;
D O I
10.1378/chest.125.1.27
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Numerous studies indicate, that smoking is associated with poorer outcomes in patients with cancer. The aim of this study was to determine whether smoking independently predicts survival in patients with lung cancer or whether an existent effect is mediated through comorbidity and/or treatment. Design and setting: Cox proportional hazards analysis was used to study a cohort of 1,155 patients with lung cancer diagnosed at the Henry Ford Health System between 1995 and 1998, inclusive. Results: Adjusted for the baseline covariates, age, gender; illicit drug use, adverse symptoms, histology, and stage, the hazard ratio (HR) for smoking (current vs former/never) was 1.37 (95% confidence interval [CI], 1.18 to 1.59; p < 0.001). Adjusted for the baseline covariates and for IS deleterious comorbidities, the HR for smoking was 1.38 (95% CI, 1.18 to 1.60; p < 0.001), indicating that the hazardous effect of smoking was not mediated through comorbidity. Current smoking was inversely associated with treatment (any surgery and/or chemotherapy and/or radiation therapy vs none) [odds ratio, 0.73; 95% CI, 0.55 to 0.98 (p = 0.03)]. Adjusted for baseline covariates, comorbidities and treatment, the HR for current smoker vs former/never was 1.26 (95% CI, 1.08 to 1.47; p = 0.003), a decline of 30.7% explained by treatment (HR for any treatment vs none, 0.40; 95% CI, 0.33 to 0.48; p < 0.001). Conclusions: Current smoking at diagnosis is an important independent predictor of shortened lung cancer survival. That this effect was not explained by sociodemographic/exposure factors, adverse symptoms, histology, stage, comorbidity, and treatment suggests that it may be mediated through direct biological effects.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 93 条
[1]  
[Anonymous], 1982, AM J CLIN PATHOL, V77, P123
[2]   LUNG-CANCER, IMMUNE STATUS, HISTOPATHOLOGY AND SMOKING - IS OAT-CELL CARCINOMA LYMPHO-DEPENDENT [J].
ANTHONY, HM ;
MADSEN, KE ;
MASON, MK ;
TEMPLEMAN, GH .
BRITISH JOURNAL OF DISEASES OF THE CHEST, 1981, 75 (01) :40-54
[3]  
ARCHIMBAUD E, 1989, CANCER-AM CANCER SOC, V63, P2060, DOI 10.1002/1097-0142(19890515)63:10<2060::AID-CNCR2820631031>3.0.CO
[4]  
2-2
[5]  
BEAHRS OH, 1993, MANUAL STAGING CANC
[6]  
BERGMAN B, 1988, EUR RESPIR J, V1, P932
[7]   CARCINOEMBRYONIC ANTIGEN (CEA), TISSUE POLYPEPTIDE ANTIGEN (TPA) AND OTHER PROGNOSTIC INDICATORS IN SQUAMOUS-CELL LUNG-CANCER [J].
BUCCHERI, G ;
FERRIGNO, D ;
VOLA, F .
LUNG CANCER, 1993, 10 (1-2) :21-33
[8]  
BUNDGAARD T, 1994, ORAL ONCOL, V30B, P323
[9]  
Coughlin SS, 1997, CANCER-AM CANCER SOC, V79, P2171, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2171::AID-CNCR15>3.3.CO
[10]  
2-5